30 Technology
AcquiredDelivering the full potential of therapeutic nitric oxide
- Headquarters
- London
- Employees
- 1–10
- Business Model
- B2B
- Website
- 30.technology
- Acquisition Date
- Apr 2023
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
30 Technology is a privately owned biopharmaceutical developer of nitric oxide-generating technologies for healthcare applications. Its proprietary platform delivers sustained, high-dose nitric oxide in inhaled liquids, topical gels, and dry powders, with customizable doses and treatment durations. The company initially targets respiratory disease, oral health, dermatology, rare diseases, and animal health, while its lead respiratory candidate generates nitric oxide at the airway surface to treat chronic drug-resistant infections.
Summary
30 Technology is a Biotech company based in London, United Kingdom. Investors include ConvaTec Group Plc.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Exit History
Apr 2023
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/30-technology"><img src="https://indexed.vc/api/badge/company/30-technology" alt="30 Technology on Indexed.vc" width="260" height="76" /></a>